February 01, 2013 at 18:20 PM EST
Regeneron, Other Biomed Stocks Rebound On New Drugs
Three biotech stocks appeared in the Spotlight screen Friday, as their fortunes have revived thanks to acquisitions and promising new drugs. Alkermes (ALKS), The Medicines Co. (MDCO) and Regeneron (REGN) are in the 236-member Medical-Biomedical/Biotech industry group, a longtime leader that was ranked No. 32 out of 197 industries as of Friday's IBD. IBD 50 stock The Medicines Co., a developer of heart and blood-thinning drugs, is well out of
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here